3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Squamous Cell Carcinoma of Head and Neck
3
Small Cell Lung Carcinoma
2
Neoplasms
2
Fallopian Tube Neoplasms
2
Uterine Neoplasms
1
Triple-negative Metastatic Breast Cancer
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Myelodysplastic-Myeloproliferative Diseases
1
Lung Neoplasms
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Acute
1
Laryngeal Neoplasms
1
Glioblastoma
1
Colorectal Neoplasms
1
Chromosome 5q Deletion Syndrome
1
Carcinoma, Ovarian Epithelial
1
Carcinoma
1
Interventions
Cisplatin
25
Cetuximab
12
Radiotherapy
11
Docetaxel
11
Fluorouracil
9
Carboplatin
9
Surgical Procedures, Operative
8
Radiotherapy, Intensity-Modulated
8
pembrolizumab
7
Magnetic Resonance Spectroscopy
7
Radiation
6
Surveys and Questionnaires
5
Specimen Handling
5
Drug Therapy
5
toripalimab
4
Standard of Care
4
Celecoxib
4
1,2-diaminocyclohexaneplatinum II citrate
4
X-Rays
3
Platinum
3
Paclitaxel
3
Nutritional Status
3
Interviews as Topic
3
Hydroxyurea
3
Counseling
3
Biopsy
3
130-nm albumin-bound paclitaxel
3
Taxes
2
Resistance Training
2
Psychiatric Rehabilitation
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Laryngeal Neoplasms
×
adavosertib
×
Clear all
NCT03028766
2024-09-19
WISTERIA
University of Birmingham
Phase 1
Completed
9 enrolled